The exploding marijuana industry is rife with indirect plays that could be safer bets on growth because they’re involved in non-cannabis niches as well. One such stock is Psychemedics (NSDQ: PMD), a drug-testing firm. Unlike many direct marijuana opportunities, this firm is generating real revenue and profits. The question is… Read More

Uranium is one of the most specialized chemical elements on the planet. Its commercial use is limited to fueling power plants and making weapons. The best uranium stocks to buy now are those that have an inside track on those markets. The nuclear energy sector has undergone considerable change during… Read More

How would you like to profit from a stock that you think will rise significantly in the short term while limiting your loss if it tanks? If so, then you should check out the short broken butterfly options strategy. As the name implies, a short broken butterfly (or short skip-strike… Read More

The marijuana boom is one of the greatest investment frenzies we’ve seen since the dot.com bubble of the late 1990s. Will the “green rush” end the same way, with pain for investors? You can make a lot of money in cannabis, as long as you remain prudent in your stock… Read More

Marijuana is a compelling investment theme, but you should shun the proliferating number of tiny penny stocks. Before investors can cry “Oh, the humanity,” many of these dubious cannabis ventures will crash and burn in spectacular fashion, like the Hindenburg. You’ve heard of the smart money? Well, there’s also a… Read More

If you’re an active options trader (or planning to become one), you’ll want to choose an affordable online trading platform that offers outstanding service. For many options traders, that choice comes down to Interactive Brokers Group (IEX: IBKR) versus Tastyworks. But which one is best? The answer to that question… Read More

Some of the best marijuana stocks are indirect plays on the industry. If pot goes bust, these firms can still rely on other core operations. GreenGro Technologies (OTC: GRNH) is an indirect marijuana play getting investor attention these days. It’s the sort of company we call “cannabis adjacent.” These are… Read More

So you’d like to start day-trading options for income? That’s great, but first you need to know about the nature of options and the risks involved. Otherwise, you could end up losing a lot of money. Beyond that, you need to develop the self-confidence necessary to become a profitable day-trader. Read More

When I was 12 years old, my dad took me to the local movie theater to see Woodstock, a film that blew my little adolescent mind. By the time the lights came up, I had outgrown Disney. Marijuana, of course, played a prominent role in this Academy Award-winning 1970 documentary… Read More

How would you like to earn a healthy return from a stock that you think will drop moderately in the near future? You can do that without even shorting the stock if you trade a bear put spread. A bear put spread is similar to a long put except that… Read More

Medicine Man Technologies (OTC: MDCL) belongs to a fast-growing marijuana industry niche: consulting and infrastructure services. Medicine Man is not a marijuana producer. The chattering class on Wall Street is infatuated with cannabis stocks. But with Medicine Man, we must raise several caveats. Not only is this a marijuana play,… Read More

The marijuana “green rush” is one of the biggest investment opportunities you can find. But you need to be selective. In this article, we scrutinize AmeriCann (OTC: ACAN) and its prospects for 2019. AmeriCann is a penny stock that has no real revenue or earnings, and plenty of debt. As… Read More

How would you like to earn a healthy return from a stock that you think will rise moderately in the near future? You can do that without buying the stock if you trade a bull put spread. A bull put spread is similar to a short put, except there’s less… Read More

Investing Daily is not a registered investment adviser or broker/dealer. All information provided on the Investing Daily network of websites is
provided as-is and does not represent personalized investment advice. These sites do not constitute a representation by the publisher or a solicitation for
the purchase or sale of securities. All opinions provided are based on sources believed to be reliable and are written in good faith, but no warranty or
representation, expressed or implied, is made as to their accuracy. There are risks associated with any investment and we strongly encourage readers to
supplement the information in these articles, special reports, and newsletters with independent research and other professional advice before investing in any security.